• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Value of contrast-enhanced ultrasound for vascular diseases of the liver - current indications and open questions
Z Gastroenterol. 2022 Dec 15. doi: 10.1055/a-1973-5731. Online ahead of print.ABSTRACTContrast-enhanced ultrasonography (CEUS) is a widely available and well-tolerated technique that can expand the diagnosis of a variety of vascular liver diseases. This paper presents an overview of the current possibilities of the use of CEUS in vascular liver diseases. Particularly where Doppler sonography has technical limitations, CEUS provides additional opportunities to visualize vascular thrombosis and other obstructions restricting blood flow. When CT or MRI contrast agents cannot be used because of severe allergy or renal insuffic...
Source: Zeitschrift fur Gastroenterologie - December 15, 2022 Category: Gastroenterology Authors: Isabella Wiest Ehsan Safai Zadeh Christian G örg Andreas Teufel Guido Michels Christoph F Dietrich Source Type: research

Ultrasound-based transient elastography improves the detection of liver disease in common variable immunodeficiency
Publication date: September–October 2019Source: The Journal of Allergy and Clinical Immunology: In Practice, Volume 7, Issue 7Author(s): Antonio Pecoraro, Ludovica Crescenzi, Andrea Fiorentino, Filomena Morisco, Giuseppe Spadaro
Source: The Journal of Allergy and Clinical Immunology: In Practice - September 5, 2019 Category: Allergy & Immunology Source Type: research

Surveillance for hepatocellular carcinoma with ultrasound and AFP is associated with improvements in tumour detection, receipt of curative therapy and overall survival in patients with cirrhosis
Commentary on: Singal AG, Pillai A, Tiro J. Early detection, curative treatment, and survival. Rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis. PLoS Med 2014;11:e1001624. Context Hepatocellular carcinoma (HCC) represents a significant global health burden: HCC is the third most common cause of cancer death worldwide.1 Established risk factors for HCC include chronic liver disease, hepatitis B viral infection, hepatitis C viral infection and inherited metabolic diseases.2 Surveillance for HCC using ultrasound is recommended by the American Association for the Study of Liver Diseas...
Source: Evidence-Based Medicine - November 19, 2014 Category: Internal Medicine Authors: Bischof, D. A., Pawlik, T. M. Tags: Liver disease, Clinical trials (epidemiology), Epidemiologic studies, Immunology (including allergy), Hepatitis and other GI infections, Screening (oncology), Radiology, Hepatitis (sexual health), Clinical diagnostic tests, Radiology (diagnostics) Thera Source Type: research